Dr. Karim Chamie

Dr. Karim Chamie, MD, MSHS, is a nationally respected urologic oncologist renowned for his expertise in the surgical and multidisciplinary treatment of bladder, kidney, and prostate cancers. He serves as an Associate Professor of Urology at the David Geffen School of Medicine at UCLA and is an integral member of the UCLA Institute of Urologic Oncology. Dr. Chamie earned his medical degree from the University of Southern California, completed his residency at UCLA, and pursued fellowship training in urologic oncology at the same institution. He also holds a Master of Science in Health Services from the UCLA Fielding School of Public Health, underscoring his commitment to evidence-based clinical care and health outcomes research.

Dr. Chamie is widely recognized for his work on bladder cancer detection, treatment optimization, and health disparities in cancer care. His research has focused on improving surveillance strategies, identifying barriers to care, and developing more effective therapeutic pathways for patients with urothelial carcinoma. He has authored numerous peer-reviewed articles and plays a central role in shaping national cancer care policies and clinical protocols through his participation in cooperative research groups and academic collaborations. His surgical expertise spans both minimally invasive and complex open procedures, guided by a patient-first philosophy.

In addition to his clinical and academic leadership, Dr. Chamie is a dedicated mentor and educator, training future urologists and advancing best practices in oncologic care. He is an active member of the American Urological Association, the Society of Urologic Oncology, and various research networks where he contributes to ongoing innovation in the field. Through his dedication to compassionate care, academic inquiry, and surgical precision, Dr. Chamie continues to impact the future of urologic oncology and improve outcomes for patients across the country.